[Adjuvant systemic therapy of breast carcinoma].
Wickramanayake
P D
PD
Klinik I für Innere Medizin, Medizinische Klinik der Universität zu Köln.
Katay
I
I
Josting
A
A
Diehl
V
V
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D015996:Survival Rate; D017211:Treatment Failure
D000970:Antineoplastic Agents